LU AA33810 - CAS 304008-29-5
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C19H25N3O2S3
Molecular Weight:
423.62
COA:
Inquire
Targets:
Neuropeptide Y receptor
Description:
LU AA33810 is a neuropeptide Y Y5 receptor antagonist. It exhibits anxiolytic- and antidepressant-like effects in rat models of stress sensitivity.
Purity:
≥98% by HPLC
Synonyms:
N-[[trans-4-[(4,5-Dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]methanesulfonamide
MSDS:
Inquire
InChIKey:
UWSBTSAJZMIHBL-UHFFFAOYSA-N
InChI:
InChI=1S/C19H25N3O2S3/c1-27(23,24)20-12-13-6-8-14(9-7-13)21-19-22-18-15-4-2-3-5-16(15)25-11-10-17(18)26-19/h2-5,13-14,20H,6-12H2,1H3,(H,21,22)
Canonical SMILES:
CS(=O)(=O)NCC1CCC(CC1)NC2=NC3=C(S2)CCSC4=CC=CC=C43
1.Antidepressant-like activity of the neuropeptide Y Y5 receptor antagonist Lu AA33810: behavioral, molecular, and immunohistochemical evidence.
Domin H;Szewczyk B;Pochwat B;Woźniak M;Śmiałowska M Psychopharmacology (Berl). 2017 Feb;234(4):631-645. doi: 10.1007/s00213-016-4495-3. Epub 2016 Dec 14.
RATIONALE: ;It has recently been found that chronic treatment with the highly selective, brain-penetrating Y5 receptor antagonist, Lu AA33810 [N-[[trans-4-[(4,5-dihydro [1] benzothiepino[5,4-d] thiazol-2-yl) amino] cyclohexyl]methyl]-methanesulfonamide], produces antidepressant-like effects in the rat chronic mild stress model.;OBJECTIVE: ;In the present study, we investigated the possible antidepressant-like activity of Lu AA33810 in rats subjected to glial ablation in the prefrontal cortex (PFC) by the gliotoxin L-AAA, which is an astroglial degeneration model of depression.;RESULTS: ;We observed that Lu AA33810 administered intraperitoneally at a single dose of 10 mg/kg both reversed depressive-like behavioral changes in the forced swim test (FST) and prevented degeneration of astrocytes in the mPFC. The mechanism of antidepressant and glioprotective effects of Lu AA33810 has not been studied, so far. We demonstrated the contribution of the noradrenergic rather than the serotonergic pathway to the antidepressant-like action of Lu AA33810 in the FST. Moreover, we found that antidepressant-like effect of Lu AA33810 was connected with the influence on brain-derived neurotrophic factor (BDNF) protein expression.
2.The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity.
Walker MW;Wolinsky TD;Jubian V;Chandrasena G;Zhong H;Huang X;Miller S;Hegde LG;Marsteller DA;Marzabadi MR;Papp M;Overstreet DH;Gerald CP;Craig DA J Pharmacol Exp Ther. 2009 Mar;328(3):900-11. doi: 10.1124/jpet.108.144634. Epub 2008 Dec 19.
Neuropeptide Y (NPY) regulates physiological processes via receptor subtypes (Y(1), Y(2), Y(4), Y(5), and y(6)). The Y(5) receptor is well known for its role in appetite. Based on expression in the limbic system, we hypothesized that the Y(5) receptor might also modulate stress sensitivity. We identified a novel Y(5) receptor-selective antagonist, Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]-benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide], that bound to cloned rat Y(5) receptors (K(i) = 1.5 nM) and antagonized NPY-evoked cAMP and calcium mobilization in vitro. Lu AA33810 (3-30 mg/kg p.o.) blocked feeding elicited by intracerebroventricular injection of the Y(5) receptor-selective agonist [cPP(1-7),NPY(19-23),Ala(31),Aib(32),Gln(34)]-hPancreatic Polypeptide in Sprague-Dawley rats. In vivo effects of Lu AA33810 were correlated with brain exposure > or = 50 ng/g and ex vivo Y(5) receptor occupancy of 22 to 95%. Lu AA33810 was subsequently evaluated in models of stress sensitivity. In Fischer 344 rats, Lu AA33810 (30 mg/kg p.o.) attenuated increases in plasma ACTH and corticosterone elicited by intracerebroventricular injection of [cPP(1-7),NPY(19-23),Ala(31),Aib(32),Gln(34)]-hPancreatic Polypeptide.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Neuropeptide Y receptor Products


CAS 263849-50-9 S 25585

S 25585
(CAS: 263849-50-9)

S 25585 is a potent neuropeptide Y (NPY) Y5 receptor antagonist (IC50 = 5.4, > 1000, > 10 000 and > 10 000 nM at Y5, Y1, Y2 and Y4 receptors, respectively) with...

CAS 191868-14-1 BIBO 3304 trifluoroacetate

BIBO 3304 trifluoroacetate
(CAS: 191868-14-1)

BIBO 3304 trifluoroacetate is a potent NPY Y1 receptor antagonist (IC50 = 0.38 and 0.72 nM at human and rat receptors, respectively) displaying > 2600-fold sele...

CAS 262418-00-8 BVD 10

BVD 10
(CAS: 262418-00-8)

BVD 10 is a selective NPY Y1 receptor antagonist (Ki = 25.7, 1420, 2403 and 7100 nM at Y1, Y2, Y4 and Y5 receptors, respectively) with no activity at Y4 recepto...

Neuropeptide Y (scrambled)

Neuropeptide Y (scrambled) is the control peptide for neuropeptide Y (NPY). Neuropeptide Y is a widely distributed endogenous neuropeptide involved in the contr...

CAS 153549-84-9 [D-Trp34]-Neuropeptide Y

[D-Trp34]-Neuropeptide Y
(CAS: 153549-84-9)

[D-Trp34]-Neuropeptide Y is a potent and selective NPY Y(5) receptor agonist (pEC50= 7.82, 6.28, 6.44 and > 6 at rat Y5, Y4, Y1 and Y2 receptors respectively), ...

CAS 443292-81-7 SF 11

SF 11
(CAS: 443292-81-7)

SF 11 is a selective and brain penetrating neuropeptide Y (NPY) Y2 antagonist (IC50 = 199 nM) displaying no affinity for Y1 receptor at concentrations up to 35 ...

CAS 158859-98-4 GR 231118

GR 231118
(CAS: 158859-98-4)

GR 231118 is a potent neuropeptide Y (NPY) Y1 receptor antagonist (pA2 = 10 and 10.5 at rY1 and hY1 receptors, respectively) and an NPY Y4 receptor agonist (pEC...

CAS 123583-37-9 Peptide YY (3-36) human

Peptide YY (3-36) human
(CAS: 123583-37-9)

Peptide YY (3-36) human, a short (36-amino acid) peptide released by cells in the ileum and colon in response to feeding, is a NPY Y2 receptor agonist. PYY (3-3...

Chemical Structure

CAS 304008-29-5 LU AA33810

Quick Inquiry

Verification code

Featured Items